Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
RLJ Lodging Trust (RLJ) | BofA Merrill Lynch/ Barclays Capital/ Wells Fargo Securities | $550.00 | 1-Star | |||
SCG Financial Acquisition (tba)(u) | Ladenburg Thalmann | 10.00 | $10.00 | $10.00 | $100.00 | n.a. |
Thermon Group Holdings (THR) | Barclays Capital/ Jefferies | $143.75 | n.a. | |||
n.a. (not available) | ||||||
SCOOP Ratings From Previous Week | ||||||
LinkedIn (tba) | Morgan Stanley/ BofA Merrill Lynch /J..P. Morgan Securities | $175.00 | 3-Stars | |||
Nexsan (NXSN) | Piper Jaffray | $69.00 | n.a | |||
Skullcandy (SKUL) | BofA Merrill Lynch/ Morgan Stanley | $125.00 | 3-Stars | |||
n.a. (not available) | ||||||
(tba – to be announced) | ||||||
Postponed | ||||||
None | ||||||
Withdrawn | ||||||
Zheng Hui Industry (ZHIC) | Rodman & Renshaw/Newbridge Securities | 1.76 | $8.00 | $9.00 | $15.00 | 1-Star |
New Terms | ||||||
BG Medicine (BGMD) | Lazard Capital Markets | 4.75 | $7.00 | $7.00 | $33.25 | 1-Star |
Endocyte (ECYT) | RBC Capital Markets/ Leerink Swann | 12.50 | $6.00 | $6.00 | $75.00 | 1-Star |
Kinder Morgan (KMI) | Goldman, Sachs/ Barclays Capital | 80.00 | $26.00 | $29.00 | $2,200.00 | 2-Stars |
Masergy Communications (MSGY) | BofA Merrill Lynch/ Deutsche Bank Securities | 7.70 | $12.00 | $14.00 | $100.10 | 2-Stars |
Pacira Pharmaceuticals (PCRX) | Barclays Capital/ Piper Jaffray | 6.00 | $7.00 | $7.00 | $42.00 | 1-Star |
IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
Week of Jan. 31, 2011 | Manager(s) | Offered | Raised | Price | 2/4/11 | Change |
Epocrates (EPOC) | J.P.Morgan/ Piper Jaffray | 5.36 | $85.76 | $16.00 | $26.51 | 65.69% |
NeoPhotonics (NPTN) | BofA Merrill Lynch/ Deutsche Bank Securities | 7.50 | $82.50 | $11.00 | $17.31 | 57.36% |
Endocyte (ECYT) | RBC Capital Markets/ Leerink Swann | 12.50 | $75.00 | $6.00 | $7.73 | 28.83% |
BG Medicine (BGMD) | Lazard Capital Markets | 5.00 | $35.00 | $7.00 | $8.05 | 15.00% |
Pacira Pharmaceuticals (PCRX) | Barclays Capital/ Piper Jaffray | 6.00 | $42.00 | $7.00 | $7.02 | 0.29% |
Tornier B.V. (TRNX) | BofA Merrill Lynch/J.P. Morgan | 8.75 | $166.25 | $19.00 | $18.38 | -3.26% |
Trunkbow International Holdings (TBOW) | Roth Capital Partners | 4.00 | $20.00 | $5.00 | $4.65 | -7.00% |